Determinants of the Implementation of Human Papillomavirus Vaccination in Zambia: Application of the Consolidated Framework for Implementation Research.

CFIR COVID-19 vaccine HPV vaccination barriers facilitators healthcare workers implementation determinants myths and misinformation parental consent teachers

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
28 Dec 2023
Historique:
received: 07 11 2023
revised: 10 12 2023
accepted: 21 12 2023
medline: 22 1 2024
pubmed: 22 1 2024
entrez: 22 1 2024
Statut: epublish

Résumé

Cervical cancer can be prevented, primarily by the administration of the human papillomavirus (HPV) vaccine. Healthcare workers (HCWs) and teachers play important roles when schools are used for vaccine delivery; however, challenges exist. This study aimed to understand the barriers and facilitators to HPV vaccination that are perceived by HCWs and teachers. Guided by the consolidated framework for implementation research (CFIR), key informant interviews were conducted in Lusaka district between June 2021 and November 2021 using a semi-structured questionnaire. Recorded interviews were transcribed verbatim and imported into NVIVO 12 for data management and analysis. We coded transcripts inductively and deductively based on the adapted CFIR codebook. We reached saturation with 23 participants. We identified barriers and facilitators across the five CFIR domains. Facilitators included offering the HPV vaccine free of charge, HPV vaccine effectiveness, stakeholder engagement, and timely planning of the HPV vaccination. Barriers included vaccine mistrust due to its perceived novelty, low levels of parental knowledge, myths and misinformation about the vaccine, lack of parental consent to vaccinate daughters, lack of transport for vaccination outreach, lack of staff incentives, and inadequate sensitisation. Using the CFIR as a guiding framework, we have identified implementation barriers and facilitators to HPV vaccination among HCWs and teachers. Most of the identified barriers are modifiable, hence it is prudent that these are addressed for a high HPV vaccine uptake.

Identifiants

pubmed: 38250845
pii: vaccines12010032
doi: 10.3390/vaccines12010032
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010558
Pays : United States

Auteurs

Mwansa Ketty Lubeya (MK)

Department of Obstetrics and Gynaecology, School of Medicine, The University of Zambia, Lusaka 10101, Zambia.
Women and Newborn Hospital, University Teaching Hospitals, Nationalist Road, Ridgeway, Lusaka 10101, Zambia.
School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 3193, South Africa.

Carla J Chibwesha (CJ)

Clinical HIV Research Unit, Helen Joseph Hospital, Johannesburg 2193, South Africa.

Mulindi Mwanahamuntu (M)

Department of Obstetrics and Gynaecology, School of Medicine, The University of Zambia, Lusaka 10101, Zambia.
Women and Newborn Hospital, University Teaching Hospitals, Nationalist Road, Ridgeway, Lusaka 10101, Zambia.

Moses Mukosha (M)

School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 3193, South Africa.
Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka 10101, Zambia.

Bellington Vwalika (B)

Department of Obstetrics and Gynaecology, School of Medicine, The University of Zambia, Lusaka 10101, Zambia.
Women and Newborn Hospital, University Teaching Hospitals, Nationalist Road, Ridgeway, Lusaka 10101, Zambia.

Mary Kawonga (M)

School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 3193, South Africa.
Department of Public Health Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg 2193, South Africa.

Classifications MeSH